FDA Approved: * December 19, 2019
Pharm Company: * WATSON LABS TEVA
Category: Gastrointestinal

Alvimopan (trade name Entereg) is a drug which behaves as a peripherally acting μ-opioid receptor antagonist. With the limited ability to cross the blood–brain barrier and reach the μ-opioid receptors of the central nervous system, the clinically undesirable effects of centrally acting opioid antagonists (like reversal of opioid-mediated analgesia) are avoided without affecting the intended blockade of μ-opioid receptors in the gastrointestinal tract.[1]&a... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Alvimopan 12 mg Oral Capsule
NDC: 0254-3012
Par Pharmaceutical, Inc.
Alvimopan 12 mg Oral Capsule
NDC: 0591-2312
Actavis Pharma, Inc.

Related Brands

Drugs with the same active ingredients